Clinical trial
PTK and Letrozole in Post-menopausal Women With Advanced Breast Cancer
NCT00263198 · Washington University School of Medicine, Other · Terminated
Key facts
| NCT number | NCT00263198 |
|---|---|
| Title | PTK and Letrozole in Post-menopausal Women With Advanced Breast Cancer |
| Official title | Phase II Study of the Combination of PTK787/ZK222584 and Letrozole in Postmenopausal Women With Advanced Hormone Receptor Positive Breast Cancer |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | Novartis Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | PTK787/ZK222584, Letrozole |
| Enrollment | 4 |
| Start date | Mar 1, 2006 |
| Primary completion | Oct 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Dec 7, 2005 |
| Last update posted | May 7, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: